HIV Seropositivity
HIV Seropositivity
Explore linked clinical trials. Standard reference: MESH:M001047114 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia | Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 2 | 2026-10-08 | NCT03519464 | |
| Thinking and Memory Problems in People With HIV | Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2026-10-08 | NCT01875588 | |
| A Multilevel, Multiphase Optimization Strategy for PrEP (MOST:PrEP) | Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Enrolling by invitation | Not applicable | 2026-09-21 | NCT06334341 | |
| Immuno-virological Evaluation of Persons Living With HIV (PLWH) | Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-09-21 | NCT05973825 | |
| Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection | Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2026-09-17 | NCT03449706 | |
| This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests. | Bacterial Infections and Mycoses, Blood-Borne Infections, Disease Attributes, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Treponema infectious disease, Urogenital Diseases, bacterial infectious disease, bacterial sexually transmitted disease, gram-negative bacterial infections, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, spirochaetales infections, syphilis, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2026-09-16 | NCT07089836 | |
| COVID-19 Serology and Immunosenescence | Blood-Borne Infections, COVID-19, Coronaviridae Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral pneumonia, viral sexually transmitted disease | Active, not recruiting | Not applicable | 2026-06-15 | NCT04563650 | |
| Clinical Trial of Gammora® Plus Antiretroviral Treatment for HIV | Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 2 | 2026-06-01 | NCT06799650 | |
| Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention | Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-04-08 | NCT05723653 | |
| Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, bacterial infectious disease, disease arising from reactivation of latent virus, gram-positive bacterial infections, immune system disorder, inborn error of immunity, infectious disease, latent tuberculosis infection, lentivirus infection, mycobacterial infectious disease, sexually transmitted disease, tuberculosis, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 1 / Phase 2 | 2025-12-12 | NCT05122026 | |
| Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, bacterial infectious disease, gram-positive bacterial infections, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, mycobacterial infectious disease, sexually transmitted disease, tuberculosis, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 4 | 2025-12-12 | NCT05118490 | |
| Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis | Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Not stated | 2025-08-28 | NCT07146529 | |
| Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin Lymphoma | Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Infections, Neoplasms by Histologic Type, RNA Virus Infections, Urogenital Diseases, immune system disorder, immunoproliferative disorder, inborn error of immunity, infectious disease, lentivirus infection, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 2 | 2025-04-09 | NCT06919679 | |
| Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis | Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, cardiovascular disorder, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, vascular disorder, vasculitis, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 1 / Phase 2 | 2024-09-19 | NCT06590545 |